BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 30101529)

  • 1. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.
    Reynolds PM; MacLaren R
    Pharmacotherapy; 2019 Mar; 39(3):408-420. PubMed ID: 30101529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.
    Zhou X; Fang H; Xu J; Chen P; Hu X; Chen B; Wang H; Hu C; Xu Z
    BMC Gastroenterol; 2019 Nov; 19(1):193. PubMed ID: 31752703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.
    Krag M; Perner A; Wetterslev J; Wise MP; Hylander Møller M
    Intensive Care Med; 2014 Jan; 40(1):11-22. PubMed ID: 24141808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.
    Toews I; George AT; Peter JV; Kirubakaran R; Fontes LES; Ezekiel JPB; Meerpohl JJ
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD008687. PubMed ID: 29862492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress ulcer prophylaxis in intensive care unit patients receiving enteral nutrition: a systematic review and meta-analysis.
    Huang HB; Jiang W; Wang CY; Qin HY; Du B
    Crit Care; 2018 Jan; 22(1):20. PubMed ID: 29374489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
    Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
    Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review.
    Krag M; Perner A; Wetterslev J; Møller MH
    Acta Anaesthesiol Scand; 2013 Aug; 57(7):835-47. PubMed ID: 23495933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients-protocol for a systematic review with meta-analysis and trial sequential analysis.
    Marker S; Perner A; Wetterslev J; Barbateskovic M; Jakobsen JC; Krag M; Granholm A; Anthon CT; Møller MH
    Syst Rev; 2017 Jun; 6(1):118. PubMed ID: 28646925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Histamine
    Hammond DA; Kathe N; Shah A; Martin BC
    Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
    Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
    Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis.
    Marik PE; Vasu T; Hirani A; Pachinburavan M
    Crit Care Med; 2010 Nov; 38(11):2222-8. PubMed ID: 20711074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic use of acid suppressants in adult acutely ill hospitalised patients: A systematic review with meta-analysis and trial sequential analysis.
    Marker S; Barbateskovic M; Perner A; Wetterslev J; Jakobsen JC; Krag M; Granholm A; Anthon CT; Møller MH
    Acta Anaesthesiol Scand; 2020 Jul; 64(6):714-728. PubMed ID: 32060905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU.
    Boyd C; Hassig T; MacLaren R
    Pharmacotherapy; 2021 Oct; 41(10):820-827. PubMed ID: 34478588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis.
    Wang Y; Ye Z; Ge L; Siemieniuk RAC; Wang X; Wang Y; Hou L; Ma Z; Agoritsas T; Vandvik PO; Perner A; Møller MH; Guyatt GH; Liu L
    BMJ; 2020 Jan; 368():l6744. PubMed ID: 31907166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses.
    Cook DJ; Reeve BK; Guyatt GH; Heyland DK; Griffith LE; Buckingham L; Tryba M
    JAMA; 1996 Jan 24-31; 275(4):308-14. PubMed ID: 8544272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: an updated systematic review and network meta-analysis of randomized trials.
    Wang Y; Ge L; Ye Z; Siemieniuk RA; Reintam Blaser A; Wang X; Perner A; Møller MH; Alhazzani W; Cook D; Guyatt GH
    Intensive Care Med; 2020 Nov; 46(11):1987-2000. PubMed ID: 32833040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress ulcer prophylaxis versus placebo-a blinded randomized control trial to evaluate the safety of two strategies in critically ill infants with congenital heart disease (SUPPRESS-CHD).
    Mills KI; Albert BD; Bechard LJ; Duggan CP; Kaza A; Rakoff-Nahoum S; Vlamakis H; Sleeper LA; Newburger JW; Priebe GP; Mehta NM
    Trials; 2020 Jun; 21(1):590. PubMed ID: 32600393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis.
    Barbateskovic M; Marker S; Granholm A; Anthon CT; Krag M; Jakobsen JC; Perner A; Wetterslev J; Møller MH
    Intensive Care Med; 2019 Feb; 45(2):143-158. PubMed ID: 30680444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological interventions for stress ulcer prophylaxis in critically ill patients: a mixed treatment comparison network meta-analysis and a recursive cumulative meta-analysis.
    Sridharan K; Sivaramakrishnan G; Gnanaraj J
    Expert Opin Pharmacother; 2018 Feb; 19(2):151-158. PubMed ID: 29271262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials.
    Alhazzani W; Alshamsi F; Belley-Cote E; Heels-Ansdell D; Brignardello-Petersen R; Alquraini M; Perner A; Møller MH; Krag M; Almenawer S; Rochwerg B; Dionne J; Jaeschke R; Alshahrani M; Deane A; Perri D; Thebane L; Al-Omari A; Finfer S; Cook D; Guyatt G
    Intensive Care Med; 2018 Jan; 44(1):1-11. PubMed ID: 29199388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.